PHILADELPHIA — A settlement has been announced for those who paid for or reimbursed certain prescription generic drugs between May 1, 2009, and Dec. 31, 2019, in the United States.
Eligible individuals may submit a class action settlement claim. The notice is authorized by federal court and is not a solicitation from an attorney.
For more information, call 1-877-316-0171 or visit www.GenericDrugsEndPayerSettlement.com.
